Clinical practices concerning central venous catheters in haematological patients

European Journal of Oncology Nursing

Volumn 14, Issue 3, 2010, Pages 200-204

  Boersma, R S ^a   Schouten, H C ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Central venous catheter related infections; Central venous catheter related thrombosis

Indexed keywords

ARTICLE; BELGIUM; BLOOD DISEASE; CANCER CENTER; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; EVIDENCE BASED PRACTICE; HEALTH CARE SURVEY; HUMAN; INCIDENCE; INDWELLING CATHETER; INFECTION CONTROL; METHODOLOGY; NETHERLANDS; NURSING; ONCOLOGY; ORGANIZATION AND MANAGEMENT; POLICY; PRACTICE GUIDELINE; SKIN CARE; STATISTICS; THROMBOSIS;

BELGIUM; CANCER CARE FACILITIES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CLINICAL PROTOCOLS; EVIDENCE-BASED PRACTICE; HEALTH CARE SURVEYS; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; INFECTION CONTROL; MEDICAL ONCOLOGY; NETHERLANDS; ORGANIZATIONAL POLICY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; SKIN CARE; THROMBOSIS;

EID: 77953539235     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2009.12.005     Document Type: Article

References (45)

1. Anonymous Recommendations for preventing the spread of vancomycin resistance. Recommendations of the hospital infection control practices advisory committee (HICPAC). MMWR Recomm Rep. 1995, 44(RR-12):1-13.
2. Abdelkefi A., Achour W., et al. Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2005, 35(4):397-401.
3. Andrivet P., Bacquer A., et al. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Clin. Infect. Dis. 1994, 18(2):199-206.
4. Biffi R., Orsi F., et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann. Oncol. 2009, 20(5):935-940.
5. Boersma R.S., Jie K.S., et al. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann. Oncol. 2008, 19(3):433-442.
6. Catton J.A., Dobbins B.M., et al. In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing. Crit. Care Med. 2005, 33(4):787-791.
7. Couban S., Goodyear M., et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J. Clin. Oncol. 2005, 23(18):4063-4069.
8. Crnich C.J., Maki D.G. Are antimicrobial-impregnated catheters effective? When does repetition reach the point of exhaustion?. Clin. Infect. Dis. 2005, 41(5):681-685.
9. Eastridge B.J., Lefor A.T. Complications of indwelling venous access devices in cancer patients. J. Clin. Oncol. 1995, 13(1):233-238.
10. Eggimann P., Hugonnet S., et al. Long-term reduction of vascular access-associated bloodstream infection. Ann. Intern. Med. 2005, 142(10):875-876.
11. Henrickson K.J., Axtell R.A., et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J. Clin. Oncol. 2000, 18(6):1269-1278.
12. Hibbard J.S., Mulberry G.K., et al. A clinical study comparing the skin antisepsis and safety of chloraPrep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine. J. Infus. Nurs. 2002, 25(4):244-249.
13. Hickman R.O., Buckner C.D., et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg. Gynecol. Obstet. 1979, 148(6):871-875.
14. Hind D., Calvert N., et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003, 327(7411):361.
15. Hirsh J., Guyatt G., et al. Antithrombotic and thrombolytic therapy: american college of chest physicians evidence-based clinical practice guidelines (eighth ed.). Chest 2008, 133(6 Suppl):110S-112S.
16. Hoffmann K.K., Weber D.J., et al. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA 1992, 267(15):2072-2076.
17. Klerk C.P., Smorenburg S.M., et al. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch. Intern. Med. 2003, 163(16):1913-1921.
18. Kovacs M.J., Kahn S.R., et al. A pilot study of central venous catheter survival in cancer patients using low molecular weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (the catheter study). J. Thromb. Haemost 2007.
19. Kumagai T., Sakamaki H., et al. Utility and safety of Hickman catheters for venous access after bone marrow transplantation. Intern. Med. 1998, 37(3):286-291.
20. Lee A.Y., Levine M.N., et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J. Clin. Oncol. 2006, 24(9):1404-1408.
21. Ljungman P., Hagglund H., et al. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer 1997, 5(6):485-488.
22. Logghe C., Van Ossel C., et al. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J. Hosp. Infect. 1997, 37(2):145-156.
23. Lordick F., Hentrich M., et al. Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study. Br. J. Haematol. 2003, 120(6):1073-1078.
24. Maki D.G., Weise C.E., et al. A semiquantitative culture method for identifying intravenous-catheter-related infection. N. Engl. J. Med. 1977, 296(23):1305-1309.
25. McConnell S.A., Gubbins P.O., et al. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?. Clin. Infect. Dis. 2003, 37(1):65-72.
26. McGee D.C., Gould M.K. Preventing complications of central venous catheterization. N. Engl. J. Med. 2003, 348(12):1123-1133.
27. Mermel L.A. Prevention of intravascular catheter-related infections. Ann. Intern. Med. 2000, 132(5):391-402.
28. Mermel L.A., Farr B.M., et al. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 2001, 32(9):1249-1272.
29. Moller T., Borregaard N., et al. Patient education - a strategy for prevention of infections caused by permanent central venous catheters in patients with haematological malignancies: a randomized clinical trial. J. Hosp. Infect. 2005, 61(4):330-341.
30. Moureau N.L. Are your skin-prep and catheter maintenance techniques up-to-date?. Nursing 2009, 39(5):15-16.
31. Mustafa B.O., Rathbun S.W., et al. Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review. Arch. Intern. Med. 2002, 162(4):401-404.
32. Niers T.M., Di Nisio M., et al. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. J. Thromb. Haemost 2007, 5(9):1878-1882.
33. Nouwen J.L., Wielenga J.J., et al. Hickman catheter-related infections in neutropenic patients: insertion in the operating theater versus insertion in the radiology suite. J. Clin. Oncol. 1999, 17(4):1304.
34. O'Grady N.P., Alexander M., et al. Guidelines for the prevention of intravascular catheter-related infections. Infect. Control Hosp. Epidemiol. 2002, 23(12):759-769.
35. Raad, Hanna H.A. Intravascular catheter-related infections: new horizons and recent advances. Arch. Intern. Med. 2002, 162(8):871-878.
36. Raad, Hohn D.C., et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect. Control Hosp. Epidemiol. 1994, 15(4 Pt 1):231-238.
37. Randolph A.G., Cook D.J., et al. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit. Care Med. 1996, 24(12):2053-2058.
38. Randolph A.G., Cook D.J., et al. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998, 113(1):165-171.
39. Safdar N., Maki D.G. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit. Care Med. 2002, 30(12):2632-2635.
40. Teichgraber U.K., Benter T., et al. A sonographically guided technique for central venous access. AJR Am. J. Roentgenol 1997, 169(3):731-733.
41. Tesselaar M.E., Ouwerkerk J., et al. Risk factors for catheter-related thrombosis in cancer patients. Eur. J. Cancer 2004, 40(15):2253-2259.
42. Trautner B.W., Darouiche R.O. Catheter-associated infections: pathogenesis affects prevention. Arch. Intern. Med. 2004, 164(8):842-850.
43. vanRooden C.J., Schippers E.F., et al. Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies. J. Clin. Oncol. 2008, 26(3):428-433.
44. Veenstra D.L., Saint S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999, 281(3):261-267.
45. Winnett G., Nolan J., et al. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol. Dial. Transplant. 2008, 23(11):3592-3598.